Reports Library

More about Nicholas Hall Reports

Sort By:

Publication Date   Alphabetically

Titles you might like:

Rx-to-OTC Switch - Success Strategies & Opportunities

Published: 30 November 2017

Author: Nicholas Hall reports

This updated edition of the best-selling 2014 report again features the knowledge and insight of Switch expert Joseph McGovern along with Nicholas Hall’s industry expertise and sales data.

Analgesics: The Evolving Self-Care Market for Pain Relief

Published: 10 October 2017

Author: Nicholas Hall Reports

This report is an in-depth exploration of the Analgesics market, including Systemic analgesics, Topical analgesics and Mouth & dental analgesics, plus supplements positioned for pain relief, and includes coverage of 16 major markets from across the globe, with topline sales, brand performances, new developments, launches and A+P campaigns.

Cold & Flu

Published: 03 August 2017

Author: Nicholas Hall's reports

This report is an in-depth exploration of the OTC Cold & Flu market, including Systemic cold & flu, Topical decongestants and Chest rubs & inhalants, plus VMS brands positioned for immunity, and includes coverage of 20 major markets from across the globe, with topline sales, brand performances, new developments, launches and A+P campaigns.

Heart Health: Exploring the OTC options

Published: 06 June 2017

Author: Nicholas Hall's Reports

More people die annually from cardiovascular diseases than from any other cause; it is the leading cause of death for both men and women.

Our newest report on Heart Health takes an in-depth look into this category, giving insight into the latest trends with detailed market analysis.

Nicholas Hall's OTC YearBook 2017

Published: 30 April 2017

Author: Nicholas Hall Reports

Same essential YearBook. Same essential price. Our best-selling title OTC YearBook is updated for 2017, providing crucial data & analysis for multinationals, local dynamos, management consultancies and any company with an interest or investment in OTC. This unique reference guide contains comprehensive market data up to December 2016, drawn from our global OTC sales database, DB6.

Healthy Ageing: The Expanding OTC Market for 50+ Consumers

Published: 28 February 2017

Author: Nicholas Hall Reports

With the population structure shifting to a new dynamic and the proportion of those aged over 50 steadily increasing, it's essential that OTC marketers cater to the specific health needs associated with older age. This vital new report explores the existing market for Healthy Ageing OTCs, as well as identifying opportunities for future growth.

OTC Dermatologicals: A Nicholas Hall report on the Global OTC Derma market

Published: 30 November 2016

Author: Nicholas Hall Reports

Nicholas Hall’s latest report will look at the factors driving performances in all the major derma markets, investigating trends on a global and local level.It contains multi-country coverage and detailed reporting of individual categories and brands. Incorporating mid-year 2016 OTC sales from Nicholas Hall’s Global OTC Database DB6, the report features the latest trends & developments, in-depth brand case studies and vital insight into factors affecting individual markets.

Eye Health - A Nicholas Hall Report on the Global Eye Health Market

Published: 31 August 2016

Author: Nicholas Hall Reports

The global market for OTC eye health products generated over $4bn in 2015, rising by around 6%. Comprising products such as eye drops, ointments, washes, decongestants, artificial tears and supplements, the eye health category is booming thanks to innovation, environmental factors, an ageing population and changing lifestyles.

A series of acquisitions since 2011 have shaken up the eye health top tier, so that the market is now dominated by a strong Top 5: Novartis (via Alcon), Allergan (merged with Actavis), Valeant (including Bausch + Lomb), Rohto and J&J. Yet, there are many smaller local and regional players enjoying phenomenal growth by carving out a specialist niche or offering innovative products.

Vitamins, Minerals and Supplements - A Nicholas Hall report on the Global OTC VMS market

Published: 01 July 2016

Author: Nicholas Hall Reports

Discover all there is to know about the Global OTC VMS market with Nicholas Hall’s latest category report, which contains multi-country coverage and detailed reporting of individual categories and brands. Incorporating year-end 2015 OTC sales, the report features the latest trends & developments, in-depth brand case studies, and vital insight into factors affecting individual markets.

M&A: A Nicholas Hall Report on Global OTC Mergers & Acquisitions

Published: 08 April 2016

Author: Nicholas Hall Reports

Mergers and acquisitions in the consumer healthcare industry are increasing in both quantity and scale at a frantic pace. The value of deals in 2014/15 alone was more than the total sum of the previous 7 years combined. This report is an invaluable resource for any company with an investment in OTC, whether you are looking to understand the acquisition strategies of your competitors, how the market dynamics have changed, or if you are searching for an M&A target of your own.

Women's Health: Obstacles & Opportunities

Published: 31 March 2015

Author: Nicholas Hall Reports

Nicholas Hall updates its successful Women’s Health report, taking a new look at this key consumer group. While women are often stereotyped as proactive health-seekers, in truth the OTC women’s health category has significant areas of untapped potential.

Global OTC Gastrointestinals

Published: 27 February 2015

Author: Nicholas Hall Reports

Nicholas Hall's Reports present the OTC Gastrointestinals category review, offering multi-country coverage of one of the largest branches on the OTC tree, with GIs currently accounting for 12% of the global self-medication market. The report uses mid-2014 sales data from Nicholas Hall's Global OTC Database, DB6 to review the latest trends & developments, as well as providing essential insight into factors affecting individual brands and categories, including antacids, laxatives and antinauseants. Available as a full report, or individual country chapters.


Successful OTC Brands Volume 2: Investigating Strategies for Success

Published: 30 October 2014

Author: Nicholas Hall Reports

Continuing our Successful OTC Brands series, this second volume follows up with a new set of case studies into the most successful brands from across the OTC industry. The report offers analysis on how A+P support (including social media), product innovation and positioning helped these brands achieve success.


Men's Health: An Untapped OTC Market

Published: 20 July 2014

Author: Nicholas Hall in collaboration with EMHF

This report will investigate the options available to OTC marketers, considering men’s health in context, the current OTC areas of particular relevance to men and how switch can expand the men’s OTC market. It will analyse what can be done to change men’s attitudes to their own health, how the role of the pharmacy can be expanded and which advances in technology offer solutions.


Direct Selling of OTC
Direct Selling of OTC: A short guide to the Direct Sales Channel, Markets & Major Players, with Recommendations for OTC

Published: 31 January 2014

Author: Nicholas Hall Reports

This short report runs to 80+ pages, covering the main markets, profiles of key players, marketing trends (consumer engagement initiatives, brand ambassadors, online tools) and strategic recommendations for OTC players. Sales data includes 2012 & 2011 OTC direct sales by country, region & global, plus OTC revenues from leading OTC direct marketers globally and in the main markets.


OTC in the Nordic Markets: A guide to the OTC markets of Denmark, Finland, Norway and Sweden

Published: 02 October 2013

Author: Nicholas Hall Reports

OTC growth in the larger markets of Western Europe has proved disappointing in recent years, with an overall sales drop in 2012. Specifically, the Big 5 are struggling: sales in France continue their decline, dropping by 6% in 2012, while the once vibrant Spain also experienced a downturn in fortunes, with sales down 2%. With such lacklustre performances, OTC marketers may need to expand their presence in the region, looking to smaller but more dynamic markets.